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During invasion of host cells, Chlamydia pneumoniae secretes the
effector protein CPn0678, which facilitates internalization of the
pathogen by remodeling the target cell’s plasma membrane and
recruiting sorting nexin 9 (SNX9), a central multifunctional endo-
cytic scaffold protein. We show here that the strongly amphipathic
N-terminal helix of CPn0678 mediates binding to phospholipids in
both the plasma membrane and synthetic membranes, and is suf-
ficient to induce extensive membrane tubulations. CPn0678 inter-
acts via its conserved C-terminal polyproline sequence with the
Src homology 3 domain of SNX9. Thus, SNX9 is found at bacte-
rial entry sites, where C. pneumoniae is internalized via EGFR-
mediated endocytosis. Moreover, depletion of human SNX9 signif-
icantly reduces internalization, whereas ectopic overexpression of
CPn0678–GFP results in a dominant-negative effect on endocytotic
processes in general, leading to the uptake of fewer chlamyd-
ial elementary bodies and diminished turnover of EGFR. Thus,
CPn0678 is an early effector involved in regulating the endocytosis
of C. pneumoniae in an EGFR- and SNX9-dependent manner.
effector protein | membrane modulation | lipid binding | endocytosis
All members of the Chlamydiaceae are obligate intracellularpathogens of humans and animals, and cause a variety of
diseases depending on the tissues they target (1). The two species
that affect humans are Chlamydia trachomatis and Chlamydia
pneumoniae, which are the causative agents of severe urogenital
conditions, including pelvic inflammation and ectopic pregnan-
cies, and respiratory disorders such as pneumonia and bronchitis,
respectively (2, 3). C. pneumoniae infections are also associated
with several chronic diseases, including asthma, Alzheimer’s
disease, multiple sclerosis, and even lung cancer (4–7).
The most critical step in the life cycle of an obligate in-
tracellular bacterium is internalization into the host cell. The
most common entry strategies are 1) the “zipper” and 2) the
“trigger” mechanisms. In the former, a bacterial adhesin/invasin
interacts with a surface receptor, thereby activating its down-
stream signaling machinery and effectively hijacking receptor
endocytosis for bacterial internalization. In the latter, an initial
and rather weak interaction between pathogen and host is rap-
idly followed by translocation of bacterial proteins, called ef-
fectors, into the host cytoplasm. These effectors modulate the
host cytoskeleton and induce extensive ruffling of the plasma
membrane (PM) to facilitate pathogen entry (8). Both mecha-
nisms involve the use of bacterial proteins to manipulate essen-
tial components of the endocytic machinery, such as the
phosphoinositide-converting enzymes that regulate the lipid
composition (and hence the curvature) of the PM (9, 10),
adaptors and regulators like sorting nexin 9 (SNX9) that control
endocytosis and vesicle trafficking (11, 12), and finally actin
polymerization, which facilitates bacterial uptake (13, 14). In-
terestingly, SNX9 harbors a membrane-curvature–sensing bin-
amphiphysin-rvs (BAR) domain and binds preferentially to
membranes of high curvature (15). Using an in vitro system it has
been proposed that binding to PI(4,5)P2, the early endosome
marker PI(3)P, and domains of high membrane curvature re-
cruits SNX9 in order to trigger the actin machinery and complete
endocytosis (16).
Internalization is preceded by stable adhesion to the host cell,
which induces intracellular signaling and recruitment of endocytosis-
related proteins. Recently, host receptors like the ephrin receptor
(EPHA2) or EGFR have been shown to promote adhesion of C.
trachomatis, but the chlamydial interaction partner remains un-
defined, as does the mechanism of entry (17, 18). For C. pneumoniae
we have shown that the pathogen uses one of its highly diverse
polymorphic membrane proteins, Pmp21, to bind and activate the
EGFR (19). EGFR activation triggers the PI3 kinase, which in turn
recruits specific endocytic adaptor proteins to facilitate the EGFR-
mediated endocytosis of C. pneumoniae (20). In addition to this
zipper mechanism, C. pneumoniae employs the trigger approach to
enter host cells. Simultaneously with the Pmp21–EGFR interaction,
C. pneumoniae secretes its TarP ortholog CPn0572 via a type III
secretion (T3S) system. CPn0572 then binds and polymerizes actin
to enforce bacterial uptake into actin-rich structures (21).
To determine whether C. pneumoniae employs other mecha-
nisms to achieve efficient internalization, we searched for new
early effector proteins involved in these processes. Here we show
that the effector CPn0678 is also a T3S substrate, and localizes to
the PM at bacterial entry sites. CPn0678 can bind phospholipids
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in both natural and synthetic membranes, and upon expression in
human cells it generates membrane tubulations, and interacts
with the host protein SNX9, a multifunctional protein involved
in clathrin-mediated endocytosis, membrane remodeling, and
actin dynamics (12). Our data suggest that, during host-cell entry,
secreted CPn0678 binds to and curves the PM, which recruits
SNX9 to the late stages of endocytosis. These findings show that
CPn0678-induced membrane curvature plays a central role in the
uptake of C. pneumoniae.
Result
CPn0678: Prototype of a T3S Chlamydial Effector Protein. A common
feature of both chlamydial adhesins and early effectors is that they
are expressed late in the preceding infection, and displayed on the
elementary body (EB) or stored within it for early secretion.
Therefore, we performed a genome-wide transcriptional analysis
to screen for such genes and found 88 genes to be significantly up-
regulated (SI Appendix, Table S1). This set included genes for
previously described adhesins, components, and potential sub-
strates of the T3S system, and hypothetical genes. Among the
latter class, we identified a highly up-regulated cluster of three
genes comprising cpn0676, cpn0677, and cpn0678. RT-PCR con-
firmed that their transcript levels increased significantly from 36 h
onward, with cpn0677 and cpn0678 RNAs becoming more abun-
dant than cpn0676 (Fig. 1A).
Comparison of the C. pneumoniae cpn0676-cpn0678 locus with
other chlamydial genomes showed that the genes are part of a
syntenic locus. CPn0676 is conserved among all Chlamydia spe-
cies with approximately 39 to 44% identity, while comparison of
CPn0677 and CPn0678 revealed a more complex pattern. All
other species have only one gene at this locus, while C. pneu-
moniae carries two genes, cpn0677 and cpn0678 (Fig. 1B).
CPn0678 itself harbors three conserved proline-rich repeats
(PRR), two of which are conserved within the N-terminal seg-
ment of CPn0677 and are 67% identical to each other (Fig. 1C).
In-depth comparisons with other chlamydial species revealed
that these two proteins are C. pneumoniae-specific, displaying no
or only low homology to other chlamydial proteomes. Thus, we
generated a phylogenetic tree showing the relationships across
the chlamydial kingdom by comparing full-length CPn0678 with
the syntenic proteins of various species (SI Appendix, Fig. S1A).
The most distantly related proteins, with less than 5% identity to
CPn0678, are found in C. trachomatis, Chlamydia muridarum,
and Chlamydia suis (Fig. 1B and SI Appendix, Fig. S1A). One of
these is C. trachomatis TmeA (CT_694), a known T3 effector
protein, which interacts with the host protein AHNAK and is
involved in early steps in the C. trachomatis infection (22, 23).
Although the three species are closely related, C. trachomatis
TmeA shares only 50 to 55% identity with its homologs in C. suis
and C. muridarum, possibly suggesting differences in their
functions. The syntenic proteins from Chlamydia abortus, Chla-
mydia felis, Chlamydia psittaci, and Chlamydia caviae share higher
levels of identity with CPn0678 (SI Appendix, Fig. S1A), ranging
between 34% and 40%. This is because the PRR1 and PRR2 of
CPn0678 are conserved among the homologous proteins in these
four species (SI Appendix, Fig. S1A). Among them is SinC
(G5Q_0070), an effector expressed by C. psittaci, which asso-
ciates with the nuclear membrane during late stages of infection
(24). These findings clearly demonstrate that this genomic locus
encodes effector proteins with diverse functions in different
chlamydial species.
To confirm that CPn0677 and CPn0678 are T3S effector
proteins, we used a heterologous Shigella flexneri T3S assay (25).
The first 25 N-terminal amino acids of each protein were fused
to the calmodulin-dependent adenylate cyclase (Cya) reporter
protein. These constructs were then separately expressed in a S.
flexneri ipaB (constitutive T3S) or mxiD (deficient in T3S)-null
strain (26, 27). Fractionation experiments confirmed that both
proteins contained a T3S-competent signal sequence, as the re-
porter constructs were detectable in the supernatants, as was the
positive control IpaD, whereas the intracellular protein CRP was
retained in the pellet (Fig. 1D). In addition, confocal microscopy
of inclusions labeled with specific antibodies at 48 h post-
infection (hpi) revealed that both CPn0677 (Fig. 1E and SI Ap-
pendix, Fig. S1C) and CPn0678 (Fig. 1F and SI Appendix, Fig.
S1C) were associated with the condensed DAPI staining char-
acteristic of EBs and not with the nuclear envelope, as shown for
SinC (24). In agreement with our transcriptional studies, the two
proteins were detected from 48 to 84 hpi in lysates of infected
cells (SI Appendix, Fig. S1B). Deconvolution of stimulated
emission depletion microscopy (STED) images of EBs released
from bursting inclusions at 86 hpi showed a ring-like structure for
both proteins (Fig. 1 E and F). The protein signals in these rings
do not look continuous, but seem to be enriched in certain areas,
which perhaps indicates the clustered presence of the T3S system
preloaded with the effector proteins. Taken together, these
findings indicate that both proteins are T3S effectors, which are
secreted in the early phase of infection.
CPn0678 Is a Lipid-Binding, Membrane-Tubulating Effector Protein.
Based on our sequence comparisons and initial localization
studies, we concluded that CPn0678 could be the prototype for
the C. pneumoniae effector proteins CPn0678 and CPn0677
encoded by the syntenic locus, and in the following we describe
our efforts to uncover the function of CPn0678. As both TmeA
and SinC interact with host membranes (24, 28), we searched for
potential membrane-interacting domains and found an N-terminal
region (amino acids 47 to 64) with a strongly amphipathic char-
acter. Secondary-structure predictions revealed that this region
also carries an α-helix, so we refer to this sequence as the
amphipathic helix (APH). Projected into a helical wheel, the
amphipathic amino acids of the APH all face to one side of the
helix (Fig. 2A). The APH is conserved, albeit weakly, in CPn0677
(amino acids 48 to 65) (Fig. 1C). To understand the function of
the APH, we first studied the localization of CPn678–GFP ec-
topically expressed in living HEp-2 cells treated with the PM dye
CellMask (Fig. 2A). Imaging revealed that CPn678–GFP localizes
to the PM and induces a strong tubulation phenotype, with
CPn678-lined tubules emanating from the cell membrane into the
cytosol (Fig. 2A). Next, we introduced amino acid exchanges into
the APH in the full-length protein to elucidate whether the
predicted α-helix or the amphipathic amino acids are function-
ally involved in the observed membrane tubulation (Fig. 2 B and
C). In MutA the amino acid exchanges result in an APH with a
10-fold reduction in hydrophobicity, while the predicted α-helix
is retained (Fig. 2B); in the converse mutant MutB the α-helix is
destroyed while the hydrophobicity is increased (Fig. 2C). Ec-
topic expression and live imaging in the presence of CellMask
revealed that both mutants have lost their tubulation phenotypes
and no PM localization could be detected (Fig. 2 B and C).
To verify that the N-terminal APH is responsible for the
tubulation phenotype, we generated different deletion variants
and analyzed them under the same conditions in live imaging and
for general protein expression (Fig. 2 D and E and SI Appendix,
Fig. S2A). All variants harboring the APH (CPn0678, N-terminal
fragment [N-term], and ΔPRR1) show both localization to the
PM and a membrane-tubulating phenotype (Fig. 2D). Quantifi-
cation of phenotypes revealed that cells expressing CPn0678 or
ΔPRR1 show an ∼50% distribution of both phenotypes, while
cells expressing the N-term variant show membrane tubules in
10% of cells; otherwise we found the protein at the PM (Fig. 2E).
In contrast, localization to the PM and tubule formation were
both lost when we deleted the APH (ΔAPH) or expressed a
C-terminal fragment (C-term), indicating that the APH is indeed
essential for membrane binding (Fig. 2D).
Hänsch et al. PNAS | February 4, 2020 | vol. 117 | no. 5 | 2635
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In proteins containing a BAR domain, membrane curvature is
mediated by insertion of the APHs, which exert a bending force on
the lipid bilayer (29, 30). These membrane tubules colocalize with
the cortical actin cytoskeleton and can be enhanced or stabilized
by its chemical depolymerization (31, 32). Similarly, we observed
that the membrane tubules induced by CPn0678–GFP expression
colocalized with cortical actin (SI Appendix, Fig. S2B). When these
cells were treated with Cytochalasin D, an actin-depolymerizing
drug, 50% more cells exhibited tubules than in the control (SI
Appendix, Fig. S2C). In addition, we detected colocalization of
CPn0678–GFP tubules with microtubules (SI Appendix, Fig. S2B),
and inhibition of microtubule polymerization by nocodazole
Fig. 1. CPn0678 is a C. pneumoniae-specific T3S effector. (A) HEp-2 cells were infected with C. pneumoniae (multiplicity of infection [MOI] 100 for the period
2 to 12 hpi, MOI 5 for 24 to 96 hpi) and harvested at the indicated time points for nucleic acid isolation. Levels of cpn0677 and cpn0678 mRNA were de-
termined by qRT-PCR using a segment of the ompA gene as the genomic reference. Data are represented as means ± SEM. (B) Schematic representation of the
C. pneumoniae gene cluster cpn0676-cpn0678 and the syntenic loci of C. trachomatis and C. psittaci. Percentage amino acid sequence identity between
homologs (C. psittaci vs. C. pneumoniae, C. trachomatis vs. C. pneumoniae) is indicated. (C) Domain structure and sequence comparison of CPn0677 and
CPn0678. The position of the APH is highlighted in yellow. (D) Chimeric proteins consisting of the first 25 amino acids of CPn0677 or CPn0678 fused to the
reporter Cya were expressed in ipaB (T3S+) and mxiD (T3S−) mutant strains of S. flexneri. Supernatant (S) and pellet (P) preparations were fractionated by
SDS/PAGE and probed with antibodies against Cya, IpaD, or CRP. (E and F, Left) Confocal images of HEp-2 cells infected for 48 h with C. pneumoniae were
fixed with PFA, permeabilized with methanol, and stained with specific antibodies against CPn0677 (E) or CPn0678 (F) and anti-rabbit Alexa488. The inclusion
membrane was stained with anti-IncA and anti-mouse Alexa594. DNA of host and bacteria was labeled with DAPI. The area in the white box is shown at
higher magnification in the Inset (Top two rows, Center). White arrows indicate stained EBs. (Scale bars, 5 μm.) (Right) EBs released from HEp-2 cells infected
for 84 h were fixed with PFA, permeabilized with methanol and stained with anti-CPn0677 (E) or CPn0678 (F) and anti-rabbit Alexa488. STED images of EBs
were generated with a Leica TCS SP8 STED 3× microscopy system. Deconvolution was performed using Huygens Professional with standard parameters. (Scale
bars, 0.5 μm.)
2636 | www.pnas.org/cgi/doi/10.1073/pnas.1911528117 Hänsch et al.
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treatment completely suppressed tubule formation (SI Appendix,
Fig. S2C). These findings indicate that cortical actin and the mi-
crotubule cytoskeleton play an important role in CPn0678-
mediated membrane tubulation.
Using giant unilaminar vesicles (GUVs), a model system for
biological membranes, we analyzed the membrane and lipid in-
teractions of CPn0678 in more detail (Fig. 3). These GUVs are
based on 69.75 mol% dipalmitoylphosphatidylcholine (DOPC)
and 25 mol% cholesterol stained with Texas red (0.25 mol%).
During vesicle assembly, additional selected phosphatidylinosi-
tols (PIPs) are incorporated, while in phosphatidylserine (PS)-
containing GUVs the lipid composition is changed to 49.75 mol%
DOPC/25 mol% cholesterol/0.25 mol% Texas red and 20 mol%
PS. Quantification of confocal images revealed that FITC-
labeled recombinant CPn0678 binds to all of the tested lipids,
and shows the highest affinities for PS, the most abundant neg-
atively charged phospholipid in the PM (33), and PIP4, a phos-
pholipid found in Golgi membranes which is the precursor of
PIP4,5 in the PM (34) (Fig. 3 A and B). Deletion of the PRR1
did not significantly affect binding, whereas deletion of the APH
completely abolished lipid interaction (Fig. 3 A and B), in-
dicating that the APH mediates the interaction of CPn0678 with
lipids, especially those found in the inner leaflet of the PM (35).
During these analyses, we observed that GUVs incubated with
Fig. 2. The N-terminal APH of CPn0678 mediates binding to the PM and triggers tubulation of the PM. (A) The region encompassing residues 40 to 70 of
CPn0678 was analyzed for hydrophobicity, hydrophobic moment and amino acid composition using HeliQuest (heliquest.ipmc.cnrs.fr) and a segment dis-
playing a with strongly amphipathic character was identified (amino acids 47 to 64, highlighted in yellow), which is presented as a helical wheel (APH) with
amphipathic amino acids in yellow and polar residues in blue. Secondary-structure prediction with GORIV (https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.pl?
page=/NPSA/npsa_server.html) revealed the presence of an α-helix (amino acids 47 to 58, represented by blue “h”). (B and C) Mutational analyses were
performed using both predictions to generate a mutant with a major loss of hydrophobicity (MutA, B) and one in which the α-helical structure was disrupted
(MutB, C). Fluorescence images of living cells expressing CPn0678-GFP (A), MutA (B), or MutB (C) treated with the PM dye CellMask. (Scale bars, 10 μm; 1 μm in
Insets.) (D) Schematic representation of the fragments of CPn0678 which were C terminally fused with GFP and used in live-cell imaging following treatment
with CellMask. White arrowheads show membrane tubulations emanating from the PM. (Scale bars, 10 μm.) (E) Quantification of subcellular localization of
Cpn0678, N-term and ΔPRR1 fused with GFP. Data are represented as means ± SD (n = 3).
Hänsch et al. PNAS | February 4, 2020 | vol. 117 | no. 5 | 2637
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binding-competent CPn0678 variants developed membrane tu-
bules on their surfaces, especially those containing the negatively
charged PS (Fig. 3A, white arrowheads). Thus, we generated
GUVs composed of PIP4,5 and PS to more closely approximate
the phospholipid mixture on the PM, and imaged them in the
absence or presence of different FITC-labeled CPn0678 variants.
All variants harboring the APH domain (CPn0678, N-term, and
ΔPRR1) elicited membrane tubulation on the GUVs, while
ΔAPH did not bind to the GUVs, as shown previously (Fig. 3 C
and D and Movies S1–S5). Quantification of GUVs incubated
with CPn0678, N-term, and ΔPRR1 revealed that 90 to 100% of
them showed membrane tubulations, while only 12% of GUVs
incubated with ΔAPH showed tubulation which is close to the
value for control GUVs (11%) (Fig. 3D). Furthermore, we ob-
served that GUVs incubated with N-term showed a marked ten-
dency to burst during incubation; bursting also occurred in GUVs
treated with CPn0678, but with a lower frequency (Movies S1–S5),
indicating that the tubulation elicited by the APH-carrying vari-
ants is strong enough to disturb the integrity of the GUVs.
CPn678-Induced Membrane Tubulation Enables the Protein to Interact
with the Endocytic Scaffold Protein SNX9. Based on our previous
findings, we hypothesized that CPn0678 is an early effector se-
creted via T3S. Therefore, we next analyzed the localization of
Fig. 3. CPn0678 binds to and tubulates artificial membranes. (A and B) Lipid binding assay using FITC-labeled recombinant CPn0678 variants and Texas red-
stained GUVs containing the indicated lipids. (A) Confocal images of GUVs incubated with CPn0678 variants. White arrowheads indicate membrane deformations.
(Scale bars, 10 μm.) (B) Quantification of microscopic analyses of protein binding expressed as the mean fluorescence of sets of 50 individual GUVs. Data are
presented as means ± SD (n = 3). (C and D) Lipid binding assay using FITC-labeled recombinant CPn0678 variants and Texas red-stained GUVs containing PS and
PIP4,5. (C) Confocal images of GUVs bound by FITC-labeled recombinant CPn0678 variants. White arrowheads indicate membrane deformations leading to
disruption of GUVs, as shown in Movies S1–S5. (Scale bars 5 μm.) (D) Quantification of analyses of membrane deformation in samples containing 50 individual
GUVs each. Data are presented as means ± SD (n = 2). n.s., not significantly different from CPn0678; **P value of 0.01; ***P value of 0.001.
2638 | www.pnas.org/cgi/doi/10.1073/pnas.1911528117 Hänsch et al.
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endogenous CPn0678 at 15 min postinfection, at which time
adhesion and internalization of C. pneumoniae can be observed
by colocalization of EBs with the host EGF receptor (20). As
expected, we found that CPn0678 colocalized with EGFR at
EB contact sites on the PM and in endocytic invaginations
containing internalized EBs (Fig. 4A). We quantified and vali-
dated our imaging data and 40% of EGFR+ EBs showed
colocalization with CPn0678 (Fig. 4B and SI Appendix, Fig. S3 A
and B), indicating that the protein is secreted during EGFR-
dependent adhesion and internalization. We then studied the
function of CPn0678 during the entry process. As mentioned
above, CPn0678 contains three PRR domains. Such domains are
known to mediate protein–protein interactions, most commonly
with proteins carrying Src homology 3 (SH3) domains (36, 37).
SH3 domains are small modules of 50 to 60 amino acids with a
characteristic 3D structure, which recognize the minimal motif
PxxP. Extending the motif with additional prolines and charged
amino acids increases the specificity of the PRR for defined
target proteins (38). Interestingly, SH3 domains can be found in
many proteins involved in endocytosis (39). Since C. pneumoniae
utilizes EGFR-mediated endocytosis (19), we asked whether
transfected CPn0678-GFP colocalized with various SH3-containing
proteins. We chose proteins directly related to EGFR-mediated
endocytosis, such as the endocytic adaptor proteins Grb2 (40),
c-Cbl (41), and Cin85 (42). We also selected SNX9, a key regulator
of dynamin assembly required for efficient clathrin-mediated en-
docytosis and known to be involved in actin dynamics during en-
docytosis (12, 43) (SI Appendix, Fig. S4 A and B). Coexpression
studies revealed no colocalization of CPn0678 with Cin85, c-Cbl, or
Grb2, but SNX9 colocalized with CPn0678 both at the PM and in
the CPn0678-induced tubules described above (SI Appendix, Fig.
S4A). In cells coexpressing both proteins, we observed that SNX9
relocalized to CPn0678+ tubules. Since the latter are phenotypi-
cally distinct from the tubules generated upon overexpression of
SNX9 (SI Appendix, Fig. S4C) (44), this observation is indicative of
a direct interaction. Moreover, when we immunoprecipitated
CPn0678–GFP from these coexpressing cells, we only detected
mCherry–SNX9 and none of the other SH3 proteins in the
eluted fraction, in agreement with our imaging data (SI Ap-
pendix, Fig. S4B).
We verified the SNX9–CPn0678 interaction in pulldown ex-
periments using recombinant proteins. Here, CPn0678-His was
found to interact directly with GST–SNX9 (Fig. 4C and SI Ap-
pendix, Fig. S5) in pulldowns using either His or GST resin.
SNX9 contains an SH3 domain that recognizes PRRs with a
positive charge at the N terminus [consensus (R/K)xφPxxP; φ =
hydrophobic amino acid], as do the PRRs found in dynamin and
N-WASP (43). Since this consensus sequence also occurs in the
first PRR motif (RPAPPQP) of CPn0678, we deleted either the
SH3 domain of SNX9 (ΔSH3) or the first PRR motif in CPn0678
(ΔPRR), and found that both variants had lost the ability to
interact with their respective full-length partner (Fig. 4C and SI
Appendix, Fig. S5), indicating that SNX9 and CPn0678 indeed
interact via their SH3 and PRR motifs respectively. The SH3
domain alone is sufficient for interaction, as it is capable of
pulling down CPn0678 on its own.
Finally, to test for a direct interaction between the two pro-
teins, we performed fluorescence lifetime imaging microscopy
(FLIM). In vivo, the average lifetime of CPn0678–GFP was
measured with and without coexpression of mCherry–SNX9.
Reduction of the lifetime is caused by Förster resonance energy
transfer (FRET) from a donor molecule (here CPn0678–GFP)
to an acceptor molecule (here mCherry–SNX9) in close prox-
imity (<10 nm) and thus indicates interaction in vivo. The donor
control showed an average lifetime of 2.86 ns (Fig. 4D). In
contrast, the average lifetime of CPn0678–GFP was significantly
reduced (by 256 ps) to 2.60 ns, when coexpressed with mCherry–
SNX9 (Fig. 4D). Similar levels of lifetime reduction have been
observed in other protein interaction studies and for fused
proteins (45–47).
Taken together, these data suggest that the APH directs
CPn0678 to the PM, where it can directly interact with SNX9 via
PRR and SH3 domains. To elucidate the hierarchy of these in-
teractions during recruitment of SNX9 to the secreted chla-
mydial effector, we performed further in vivo and in vitro assays
in which we measured the interaction of different CPn0678
variants—either capable of binding and tubulating the mem-
brane (CPn0678, N-term, and ΔPRR1) or not—with SNX9 and
two deletion variants (ΔBAR, ΔBARΔSH3) (Fig. 4 E and F and
Movies S6–S15). The BAR domain of SNX9 contains classic
amphipathic helices to induce membrane tubulation, although
SNX9 is better at sensing curvature than inducing it (44, 48).
While lipid binding is maintained via the PX domain, deletion of
the BAR domain disrupts membrane tubulation, and deletion of
the SH3 domain inhibits all protein–protein interactions (12).
Upon coexpression of CPn0678 with SNX9, colocalization of
both proteins on membrane tubules was dependent on the
presence of the SNX9 SH3 domain, but independent of the BAR
domain (Fig. 4E and SI Appendix, Fig. S4E).
Furthermore, CPn0678 variants lacking the PRR1 motif (i.e.,
N-term or ΔPRR1) showed no colocalization with SNX9, whereas
variants lacking the membrane localization domain, C terminus, or
APH, interacted with SNX9, although interaction was restricted to
the cytosol (SI Appendix, Fig. S4 D and E). This indicates that
CPn0678 induces the recruitment of SNX9 to membrane struc-
tures formed by the chlamydial effector. During chlamydial en-
docytosis this occurs at the PM, where secreted CPn0678 locally
deforms the membrane and recruits SNX9. To test our hypothe-
sis that CPn0678-induced membrane curvature indeed re-
cruits SNX9, we again used GUVs composed of PS and PIP4,5
(Fig. 4F and Movies S6–S15). In accordance with published data,
DyLight650-labeled SNX9 did not bind to these GUVs (Fig. 4F
and Movie S6); although it is capable of binding to PIP4,5 lipids
(49, 50), it does so only if the membranes are already curved (16).
Strikingly, when we added FITC-labeled CPn0678 to GUVs pre-
incubated with SNX9 we observed immediate binding of CPn0678
and generation of membrane tubules, to which SNX9 was sub-
sequently recruited (Fig. 4F and Movie S7). This recruitment is
dependent on the membrane-tubulating capacity of the N-
terminal APH of CPn0678, as SNX9 is recruited to the GUV
surface in the presence of membrane-modulating N-term or
ΔPRR1 variants but not ΔAPH (Fig. 4F and Movies S8–S10).
Moreover, SNX9 recruitment to GUVs is not dependent on its
own membrane-curving domain, as we observed the same pattern
of recruitment of SNX9ΔBAR to CPn0678, N-term, and ΔPRR1
but not ΔAPH variants (SI Appendix, Fig. S6 and Movies S11–
S15). Taken together, these results show that CPn0678 induces
membrane curvature which is then sensed by SNX9.
Internalization of C. pneumoniae Depends on the Interaction between
CPn0678 and SNX9. To demonstrate the interdependence of en-
dogenous SNX9 and CPn0678 during C. pneumoniae internali-
zation, we first analyzed whether SNX9 localizes to invading
EBs. Indeed, by 15 min postinfection, we were able to detect a
patch-like association of SNX9 with EBs surrounded by EGFR
(Fig. 5A). Quantification and validation of the imaging data
revealed that 47% of EBs that colocalize with EGFR are also
positive for SNX9 (Fig. 5B and SI Appendix, Fig. S3C). Next, we
performed a coimmunoprecipitation assay on cells lysed 15 min
after infection, and were able to coprecipitate CPn0678 using a
specific antibody against SNX9; conversely, SNX9 was recovered
with an antibody directed against CPn0678 (Fig. 5C). These
findings are further supported by direct colocalization of both
proteins with attaching and invading C. pneumoniae EBs (Fig.
5D). We analyzed 400 EBs for CPn0678 expression, quantified,
and validated how many of them colocalize with SNX9. Some
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Fig. 4. CPn0678 interacts with host SNX9. (A) Colocalization of CPn0678 (stained with anti-CPn0678 and anti-rabbit Alexa488) and EGFR (stained with anti-
EGFR and anti-mouse Alexa594) at bacterial entry sites at 15 min postinfection. The area in the white box is shown at higher magnification in the Inset (Right).
C. pneumoniae EBs were stained with DAPI. White arrowheads indicate instances of colocalization. (Scale bar, 10 μm; 1 μm in Insets.) (B) EBs associating with
EGFR were quantified for additional colocalization of CPn0678 signals shown in A. Confocal images of 300 individual EBs were analyzed. Data are presented
as means ± SD (n = 3). ***P ≤ 0.001. Colocalization was validated by estimating Pearsons correlation coefficients (SI Appendix, Fig. S3 A and B). (C) Pulldown
experiments using purified recombinant GST or GST–SNX9 variants (ΔSH3, SH3) and CPn067810His or CPn0678ΔPRR110His. Input and elution samples obtained
from His-pulldowns and GST-pulldowns were fractionated by SDS/PAGE and probed with anti-GST and anti-His antibodies. (D) Quantification of FLIM
measurements of average fluorescence lifetimes, used to monitor FRET from CPn0678–GFP to mCherry–SNX9. The lifetime of donor fluorescence measured in
30 to 40 cells with or without coexpression of the acceptor are depicted as a box plot generated by OriginPro. Data are presented as means ± SD (n = 3). (E)
Confocal images of cells coexpressing CPn0678–GFP and mCherry–SNX9 variants (SNX9, ΔBAR, ΔBARΔSH3). Insets show regions in white squares. (Scale bars
10 μm; 1 μm in Insets.) (F) Confocal images of Texas red-stained GUVs containing PS and PIP4,5 preincubated for 10 min with DyLight650-labeled SNX9 and
followed by addition of FITC-labeled CPn0678 variants. See Movies S6–S15 for movies of each sample. (Scale bars, 5 μm.)
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Fig. 5. Interaction of SNX9 with CPn0678 is essential for infection by C. pneumonia. (A) Colocalization of SNX9 (stained with anti-SNX9 and anti-mouse
Alexa488) and EGFR (stained with anti-EGFR and anti-rabbit Alexa594) at bacterial entry sites at 15 min postinfection. C. pneumoniae EBs were stained with
DAPI. Insets show regions in white squares. White arrowheads indicate instances of colocalization. (Scale bars 10 μm; 1 μm in Insets.) (B) A. Confocal images of
200 individual EBs were analyzed. Data are presented as means ± SD (n = 3). **P ≤ 0.01. Colocalization was validated by estimating Pearsons correlation
coefficients (SI Appendix, Fig. S3C). (C) Coimmunoprecipitation of HEp-2 cells infected or not infected with C. pneumoniae EBs (MOI 100). Cell lysates were
incubated with μMACS protein G microbeads coupled to antibodies directed against SNX9 or CPn0678. Elution samples were fractionated by SDS/PAGE and
detected with the appropriate antibodies. White asterisks mark the light chain of the antibody, the black arrow the specifically labeled CPn0678 band. (D)
Colocalization of SNX9 (stained with anti-SNX9 and anti-mouse Alexa488) and CPn0678 (stained with anti-CPn0678 and anti-rabbit Alexa594) at bacterial
entry sites at 15 min postinfection. C. pneumoniae EBs were stained with DAPI. Insets show regions outlined by white squares. White arrowheads show
colocalization. (Scale bar, 10 μm; 1 μm in Insets.) (E) EBs colocalizing with CPn0678 were quantified for additional colocalization of SNX9 signals shown in D.
Confocal images of 400 individual EBs were analyzed. Data are presented as means ± SD (n = 3). *P ≤ 0.1. Colocalization was validated by estimating Pearsons
correlation coefficients (SI Appendix, Fig. S3D). (F–H) C. pneumoniae internalization and infection of HEp-2 cells depleted of SNX9 by stably integrated shRNA
plasmids. A nontargeting shRNA served as control. (F) Immunoblot of cell lysates fractionated by SDS/PAGE and probed with antibodies against SNX9. Actin
served as the loading control. Signal intensity was quantified with ImageJ and expressed as a percentage of the actin signal. (G) Quantification of in-
ternalization of EBs into cells used in F at 2 hpi based on the examination of 40 visual fields. Data are represented as means ± SD (n = 4). **P ≤0.01, ***P ≤
0.001, n.s., not significant. (H) Quantification of infection of cells used in F at 48 hpi based on the examination of 40 visual fields. Data are represented as
means ± SD (n = 4). ***P ≤ 0.001. (I and J) Infection and EGF uptake assay of HEp-2 cells transfected for 15 h with either GFP or CPn0678-GFP. (I) Transiently
transfected cells were subjected to a C. pneumoniae infection (MOI 2), fixed at 24 hpi and the numbers of inclusions in 10 visual fields were counted and
plotted relative to the GFP control. Data are presented as means ± SD (n = 3). ***P ≤ 0.001. (J) Transfected cells were incubated with 100 ng/mL EGF-Alexa594
for 15 min, EGF uptake was measured in 10 visual fields and plotted relative to the GFP control. Data are presented as mean ± SD (n = 3) ***P ≤ 0.001.
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40% were found to show an overlap between SNX9 and CPn678
(Fig. 5E and SI Appendix, Fig. S3D). This indicates that, upon
attachment of the EB to the host cell, CPn0678 is secreted and
recruits SNX9 to the site of internalization, where both pro-
teins together facilitate the EGFR-mediated endocytosis of
C. pneumoniae.
We subsequently used a cell line that stably expresses two
different short-hairpin RNAs (shRNAs) directed against SNX9
and performed internalization and infection studies with these
cells (Fig. 5 F–H). Cells expressing shRNA B retained only 9%
SNX9 protein and showed a 50% reduction in internalization
rate compared to control cells, while cells expressing the less
effective shRNA A retained 67% of the protein, and the in-
ternalization rate felt by 30% (Fig. 5 F and G). In infection
studies both cell lines showed a comparable reduction of in-
fection (Fig. 5H), indicating that SNX9 is essential for the
C. pneumoniae internalization process.
Moreover, we generated cells with a dominant-negative en-
docytosis phenotype by transiently overexpressing CPn0678–
GFP, therefore trapping endogenous SNX9 in a CPn0678-bound
state (Fig. 5 I and J) at the PM. When we analyzed their capacity
for endocytosis by either exposing them to C. pneumoniae EBs or
labeled EGF, we observed a 50% reduction in inclusion forma-
tion in comparison to cells expressing GFP (Fig. 5I), and a 60%
reduction in uptake of EGF (Fig. 5J), showing that the chla-
mydial early effector protein CPn0678 recruits SNX9 to bacte-
rial entry sites, where both proteins facilitate the uptake of
C. pneumoniae into host cells in a concerted manner.
Discussion
Upon T3-mediated secretion, the effector protein CPn0678 de-
scribed in this work localizes to the host PM at bacterial entry
sites enriched in EGFR. CPn0678 induces membrane curvature,
which is sensed by SNX9, a key regulator of endocytosis. SNX9 is
then recruited by and binds to CPn0678 via the interaction of
its SH3 domain with the class I polyproline sequence in the
C-terminal segment of the chlamydial effector. We therefore refer
to the protein hereafter as SemC (secreted effector of membrane
curvature).
The BAR-PX domain of SNX9 binds preferentially to mem-
branes of high curvature (15). Indeed, recently it was shown that
SNX9 localizes to highly curved regions of late clathrin-coated
invaginations, which coincide with PI(4,5)P2 and PI(3)P (50, 51).
The SNX9 PX-BAR domain binds to PI(4,5)P2-containing ves-
icles primarily via the BAR domain, and with lower affinity to
PI(3)P-binding sites via the PX domain. Based on in vitro stud-
ies, it was subsequently proposed that SNX9 is recruited via its
three effectors PI(4,5)P2, PI(3)P, and membrane curvature to the
clathrin-coated invagination to locally activate the actin ma-
chinery and complete endocytosis (16).
On the basis of our results, we propose that SemC acts to
control the size and shape of the endocytic vesicle formed fol-
lowing the activation of the EGFR-mediated endocytosis ma-
chinery, which is triggered by binding of the bacterial adhesin
Pmp21 to EGFR (19). During chlamydial infection, an adjust-
ment in PM curvature is essential, because while clathrin-
mediated receptor endocytosis generates vesicles with a di-
ameter of ∼120 nm (52), chlamydial EBs have a diameter of
∼400 nm. The significantly larger size of the developing vesicle
harboring the EB exhibits significantly less curvature. SNX9
binds to membranes of clathrin-coated vesicles ∼10 times better
than to vesicles with lower curvature (16). Thus, we suggest that,
once secreted, CPn0678 binds to the inner leaflet of the host cell
PM and induces a level of curvature equivalent to that of the
developing clathrin vesicle; the curved membrane recruits SNX9,
and a direct interaction of SemC with SNX9 may facilitate and
stabilize this process. Recruitment of SNX9 and additional
endocytic components targeted by SNX9, such as dynamin for
neck constriction and N-WASP, enhance actin dynamics (12,
43, 53). We have shown here that SemC uses its APH domain to
induce membrane curvatures in synthetic membranes, such as
GUVs, which are strong enough to disrupt these vesicles. Ec-
topic expression of the effector in human cells generates tubules
emanating from the PM. Formation of SemC-induced tubules on
GUV membranes is essential for recruitment of SNX9, which by
itself does not bind to these vesicles, and tubulation is solely
dependent on the presence of the APH. Formation of membrane
tubules within cells is dependent on the actin and microtubule
cytoskeleton. SemC-induced tubulation is intensified upon re-
cruitment of SNX9, as revealed by our finding that, when over-
expressed, SNX9 strongly enhances the SemC tubule phenotype.
Furthermore, ectopic expression of SemC prior to infection
negatively influences the endocytotic capacity of cells, leading to
fewer internalized EBs and less endocytosed EGFR. These ob-
servations imply that, during internalization, secreted SemC re-
directs SNX9 function to chlamydial entry sites, which in turn
promotes the uptake of EBs.
In addition, SemC may manipulate other SNX9 functions,
such as vesicle maturation, activation of dynamin for vesicle
scission, and the regulation of actin assembly, which is essential
for membrane remodeling by interaction with N-WASP or Arp2/3
(12). Interestingly, due to this central role in endocytosis, SNX9
is targeted in different ways by other bacterial pathogens
(54, 55).
Depletion of SNX9 by shRNA reduces but does not abrogate
C. pneumoniae internalization. This can likely be accounted for
by continuing interaction of SemC with other members of the
SNX9 family, in particular SNX18 and SNX33 (56). Moreover,
this might also be indicative of the robustness of the chlamydial
host-cell entry process, which very likely relies on a variety of
chlamydial effector protein functions yet to be identified.
In conclusion, we speculate that the chlamydial effector SemC
manipulates a core process of endocytosis by binding to and
inducing curvature of the PM underneath invading Chlamydiae.
This membrane deformation recruits the central endocytotic
scaffold protein SNX9. The SemC–SNX9 interaction is direct,
and together the two proteins promote formation of a vesicle
that is large enough to accommodate an EB, and stimulate its
endocytosis by locally activating the actin machinery.
Materials and Methods
Antibodies and Reagents. The primary antibody against SNX9 (OTI1E4) was
purchased fromOrigene, anti-EGFR (PA1-1110) and anti-GFP (MA5-15256)were
from Thermo Scientific, antipenta-His (#34660) from Qiagen, anti-GST (#2622)
from Cell Signaling, and anti-DsRed (sc-101526) from Santa Cruz. Anti-IncA
was a gift from G. Zhong, University of Texas Health Science Center at San
Antonio, San Antonio, TX (57), and anti-DnaK was obtained from S. Birkelund,
Aalborg University, Aalborg, Denmark (58). Antibodies against Cpn0677 and
Cpn0678 were generated in our laboratory, as was anti-CPn0147. Mouse anti-
Cya, rabbit anti-CRP, and rabbit anti-IpaD antibodies were generously do-
nated by N. Guiso, A. Ullmann, and C. Parsot, Institut Pasteur, Paris, France,
respectively. Secondary anti-rabbit and anti-mouse antibodies coupled to
Alexa488 or Alexa594 were purchased from Thermo Scientific, and those
coupled to alkaline phosphatase were sourced from Promega. CellMask (or-
ange) and Rhodamine-Phalloidin were purchased from Thermo Scientific, and
SiR-Tubulin from Spirochrome. All lipids used in this study were obtained from
Avanti Lipids, and Texas red dye, NHS-FITC and DyLight650NHS from Thermo
Scientific. Nocodazole and Cytochalasin D were purchased from Merck.
Growth of Chlamydia, Bacteria, and Cell Lines. C. pneumoniae GiD was
propagated in HEp-2 cells (ATCC: CCL-23). HEp-2 and HEK293-T cells stably
expressing shRNA plasmids were cultured in DMEM supplemented with 10%
FCS, MEM vitamins, and nonessential amino acids (Thermo Scientific). Chla-
mydial EBs were purified using a 30% gastrographin solution (Bayer) and
stored in SPG buffer (220 mM sucrose, 3.8 mM KH2PO4, 10.8 mM Na2HPO4,
4.9 mM L-glutamine). All cloning was carried out by in vivo homologous
recombination in Saccharomyces cerevisiae. The Escherichia coli strains XL-1
Blue (Stratagene) and BL21 (DE3, Invitrogen) were used for plasmid
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amplification and protein purification, respectively. The ipaB and mxiD
strains, in which the corresponding genes (ipaB and mxiD) have been inac-
tivated (26), are derived from the virulent wild-type M90T strain of S. flexneri,
and were grown in Luria-Bertani (LB) medium supplemented with (0.1 mg/mL)
ampicillin.
Shigella Heterologous Secretion Assay. Analysis of secreted proteins was
performed as described previously (25). Briefly, 1 mL of a 30 °C overnight
culture of S. flexneri ipaB or mxiD that had been transformed with different
Cya chimeras was added to 30 mL of LB broth containing 0.1 mg/mL ampi-
cillin, and incubated at 37 °C for 4 h. For experiments using full-length proteins,
expression was induced by adding 150 μM isfopropyl-β-D-thiogalactopyranoside
(IPTG) for the 4-h growth period. Bacteria were then harvested by centri-
fugation and the supernatant was filtered through a Millipore filter (0.2 μm).
To precipitate the proteins, a one-tenth volume of trichloroacetic acid was
added to the supernatant, and both the precipitate and the bacterial
pellet were resuspended in sample buffer for analysis by SDS/PAGE and
immunoblot.
Preparation and Analysis of GUVs. GUVs were prepared as described pre-
viously (59). Briefly, PIP-containing lipid mixtures contain 69.75 mol% DOPC,
25 mol% cholesterol, and 0.25 mol % Texas red to which 5 mol% PIPs was
added. In PS-containing GUVs the mixture was changed to 49.75 mol%
DOPC/25 mol% cholesterol/0.25 mol% Texas red/20 mol% DOPS. GUVs
containing PIP4,5 and PS were prepared by mixing 44.75 mol% DOPC,
25 mol% cholesterol, 0.25 mol% Texas red, and 20 mol% DOPS with 5 mol%
PIP4,5. Lipid mixtures were prepared and added to a chamber built of ITO-
coated slides (Präzisions Glas & Optik) glued together with Vitrex (Vitrex
Medical). The cavity between the slides was filled with 10% sucrose solution
and sealed with Vitrex. The slides were connected via clamps to a frequency
generator and an alternating voltage of 2.0 Vp-p was applied at a frequency
of 11 Hz. The GUVs were grown for 2 to 3 h in the dark at room tempera-
ture. For microscopic analyses, μ-slides Angiogenesis (Ibidi) were coated for 5
to 10 min at room temperature with 2 mg/mL β-casein (Merck) and washed
with PBS. Then 10 μL of GUV solution mixed with 30 μL of PBS was added to
the slides and the GUVs were allowed to settle. Then 2 μg of NHS-FITC–
labeled recombinant protein was added and incubated for 15 min at room
temperature. For binding studies with two proteins, GUVs were first
incubated with 2 μg of NHS-650–labeled recombinant protein and imaged
for 10 min at room temperature, then 2 μg of NHS-FITC–labeled recombi-
nant protein was added and images were acquired for additional 10 min.
Images were quantified using ImageJ. For each lipid and protein combina-
tion, 50 GUVs were analyzed for their maximum fluorescence intensity on
the membrane.
Microscopy and Image Processing. General imaging was performed using an
inverse Nikon TiE Live Cell Confocal C2plus equipped with a 100× TIRF ob-
jective and a C2 SH C2 Scanner. All images were generated with Nikon NIS
Elements software and quantified using ImageJ.
Gated STED measurements were performed using a TCS SP8 STED 3×
(Leica) equipped with an HC PL APO CS2 100× objective (NA 1.4) at a scan
speed of 400 to 600 Hz. A pulsed white-light laser was used at 499 nm for
AlexaFluor488 excitation and a continuous-wave fiber laser at 592 nm was
used for excitation depletion. The detection range of the GaAsP hybrid
detector was set from 504 nm to 580 nm to collect the emitted fluorescent
signals. To further increase resolution, time gating was set from 0.5 ns to 12 ns.
Finally, deconvolved STED data were calculated using standard algo-
rithms implemented in the Huygens software (Huygens Professional, Sci-
entific Volume Imaging) on the acquired raw data.
Statistical Analyses. Statistical analyses of FLIM imaging data were performed
using OriginPro. The data represent the mean ± SD of n experiments. For
simple paired analyses between two groups, a Student’s t test was chosen. A
P value of less than 0.01 was considered to be statistically significant.
Data Availability Statement. All data are available in the manuscript and SI
Appendix.
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